The DOI matches its Crossref record; 268 of the 270 references it cites were found in a registry or an index.
Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes
Open accessAbstract
An increasing amount of research aims at recognizing the molecular mechanisms involved in long-lasting brain architectural changes induced by antipsychotic treatments. Although both structural and functional modifications have been identified following acute antipsychotic administration in humans, currently there is scarce knowledge on the enduring consequences of these acute changes. New insights in immediate-early genes (IEGs) modulation following acute or chronic antipsychotic administration may help to fill the gap between primary molecular response and putative long-term changes. Moreover, a critical appraisal of the spatial and temporal patterns of IEGs expression may shed light on the functional "signature" of antipsychotics, such as the propensity to induce motor side effects, the potential neurobiological mechanisms underlying the differences between antipsychotics beyond D2 dopamine receptor affinity, as well as the relevant effects of brain region-specificity in their mechanisms of action. The interest for brain IEGs modulation after antipsychotic treatments has been revitalized by breakthrough findings such as the role of early genes in schizophrenia pathophysiology, the involvement of IEGs in epigenetic mechanisms relevant for cognition, and in neuronal mapping by means of IEGs expression profiling. Here we critically review the evidence on the differential modulation of IEGs by antipsychotics, highlighting the association between IEGs expression and neuroplasticity changes in brain regions impacted by antipsychotics, trying to elucidate the molecular mechanisms underpinning the effects of this class of drugs on psychotic, cognitive and behavioral symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
da Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,015
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Balleine, B. W., & O'Doherty, J. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.131 · Cited by 1,775
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Lyford, G. L., Yamagata, K., Kaufmann, W. E., Barnes, C. A., Sanders, L. K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Lanahan, A. A., & Worley, P. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90299-6 · Cited by 1,212
Long-term Antipsychotic Treatment and Brain Volumes
Ho, B., Andreasen, N., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 952
Mouse and rat BDNF gene structure and expression revisited
Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., & Timmusk, T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21139 · Cited by 943
Mapping of Brain Activity by Automated Volume Analysis of Immediate Early Genes
Renier, N., Adams, E. L., Kirst, C., Wu, Z., Azevedo, R., Kohl, J., Autry, A. E., Kadiri, L., Umadevi Venkataraju, K., Zhou, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.007 · Cited by 918
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
Chen, Z.-Y., Patel, P. D., Sant, G., Meng, C.-X., Teng, K. K., Hempstead, B. L., & Lee, F. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0348-04.2004 · Cited by 874
Geddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
Arc/Arg3.1 Is Essential for the Consolidation of Synaptic Plasticity and Memories
Plath, N., Ohana, O., Dammermann, B., Errington, M. L., Schmitz, D., Gross, C., Mao, X., Engelsberg, A., Mahlke, C., Welzl, H., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.024 · Cited by 827
BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?
Lü, Y., Christian, K. M., & Lu, B. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.08.018 · Cited by 807
Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking
Chowdhury, S., Shepherd, J. D., Okuno, H., Lyford, G., Petralia, R. S., Plath, N., Kuhl, D., Huganir, R. L., & Worley, P. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.033 · Cited by 792
AP-1 in mouse development and tumorigenesis
Jochum, W., Passegue, E. A., & Wagner, E. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204389 · Cited by 734
Somatodendritic expression of an immediate early gene is regulated by synaptic activity.
Link, W., Konietzko, U., Kauselmann, G., Krug, M., Schwanke, B., Frey, U., & Kuhl, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5734 · Cited by 710
Serial two-photon tomography for automated ex vivo mouse brain imaging
Ragan, T. M., Kadiri, L. R., Venkataraju, K. U., Bahlmann, K., Sutin, J. D. B., Taranda, J., Arganda‐Carreras, I., Kim, Y., Seung, H. S., & Osten, P. (2012) · Nature Methods · doi:10.1038/nmeth.1854 · Cited by 683
Hughes, P. E., & Dragunow, M. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06819-x · Cited by 680
Cannon, T. D., Chung, Y., He, G., Sun, D., Jacobson, A., van Erp, T. G. M., McEwen, S., Addington, J., Bearden, C. E., Cadenhead, K., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.023 · Cited by 599
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Díaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 573
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001308 · Cited by 533
Messaoudi, E., Kanhema, T., Soule, J. D., Tiron, A., Dagytė, G., da Silva, B., & Bramham, C. R. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2883-07.2007 · Cited by 472
Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product narp.
O’Brien, R. J., Xu, D., Petralia, R. S., Steward, O., Huganir, R. L., & Worley, P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80782-5 · Cited by 471
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453
Bramham, C. R., Alme, M. N., Bittins, M., Kuipers, S. D., Nair, R. R., Pai, B., Panja, D., Schubert, M., Soule, J., Tiron, A., et al. (2010) · Experimental Brain Research · doi:10.1007/s00221-009-1959-2 · Cited by 452
The NR4A Subgroup: Immediate Early Response Genes with Pleiotropic Physiological Roles
Maxwell, M., & Muscat, G. E. O. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04002 · Cited by 447
Prefrontal function in schizophrenia: confounds and controversies
Weinberger, D. R., & Berman, K. F. (1996) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1996.0135 · Cited by 414
Verde, E. R., Lee‐Osbourne, J., Worley, P. F., Malinow, R., & Cline, H. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.031 · Cited by 413
Alonso, M., Medina, J. H., & Pozzo-Miller, L. (2004) · Learning & Memory · doi:10.1101/lm.67804 · Cited by 412
Xu, B., Gottschalk, W., Chow, A., Wilson, R. I., Schnell, E., Zang, K., Wang, D., Nicoll, R. A., Lu, B., & Reichardt, L. F. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06888.2000 · Cited by 404
Identification of a new brain-specific transcription factor, NURR1
Law, S. W. T., Conneely, O. M., DeMayo, F. J., & O’Malley, B. W. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.12.1491694 · Cited by 399
Balance and Stability of Synaptic Structures during Synaptic Plasticity
Meyer, D., Bonhoeffer, T., & Scheuss, V. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.031 · Cited by 395
The Neurobiology of Cocaine Addiction
Nestler, E. (2005) · Science & Practice Perspectives · doi:10.1151/spp05314 · Cited by 367
Immediate-Early Genes and Synaptic Function
Lanahan, A. A., & Worley, P. F. (1998) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3836 · Cited by 357
Pang, P. T., & Lu, B. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.07.002 · Cited by 356
New insights into the role of brain-derived neurotrophic factor in synaptic plasticity
Waterhouse, E. G., & Xu, B. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.06.009 · Cited by 352
Egr transcription factors in the nervous system
Beckmann, A. M., & Wilce, P. A. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00136-2 · Cited by 347
Shiraishi‐Yamaguchi, Y., & Furuichi, T. (2007) · Genome biology · doi:10.1186/gb-2007-8-2-206 · Cited by 343
Nguyen, T., Kosofsky, B. E., Birnbaum, R., Cohen, B. M., & Hyman, S. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4270 · Cited by 331
Calcium regulation of gene expression in neuronal cells
Ghosh, A., Ginty, D. D., Bading, H., & Greenberg, M. E. (1994) · Journal of Neurobiology · doi:10.1002/neu.480250309 · Cited by 326
Baquet, Z. C., Bickford, P. C., & Jones, K. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4601-04.2005 · Cited by 318
Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons
Chang, M. C., Park, J. M., Pelkey, K. A., Grabenstatter, H. L., Xu, D., Linden, D. J., Sutula, T. P., McBain, C. J., & Worley, P. F. (2010) · Nature Neuroscience · doi:10.1038/nn.2621 · Cited by 316
Tsui, C., Copeland, N., Gilbert, D., Jenkins, N., Barnes, C., & Worley, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02463.1996 · Cited by 315
Robertson, G. S., Matsumura, H., & Fibiger, H. C. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23800-9 · Cited by 311
Imaging the Addicted Human Brain
Fowler, J. S., Volkow, N. D., Kassed, C. A., & Chang, L. (2007) · Science & Practice Perspectives · doi:10.1151/spp07324 · Cited by 309
Vazdarjanova, A. I., McNaughton, B. L., Barnes, C. A., Worley, P. F., & Guzowski, J. F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10067.2002 · Cited by 307
González-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J. A., & Sealfon, S. C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08836.2003 · Cited by 297
Davis, S., Bozon, B., & Laroche, S. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00421-7 · Cited by 294
Ortega‐Martínez, S. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00046 · Cited by 285
Vita, A., Peri, L. M. D., Deste, G., Barlati, S., & Sacchetti, E. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.008 · Cited by 277
Fryer, R. H., Kaplan, D. R., Feinstein, S. C., Radeke, M. J., Grayson, D. R., & Kromer, L. F. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961007)374:1 · Cited by 273
Homeostatic Scaling Requires Group I mGluR Activation Mediated by Homer1a
Hu, J.-H., Park, J. M., Park, S. J., Xiao, B., Dehoff, M. H., Kim, S., Hayashi, T., Schwarz, M. K., Huganir, R. L., Seeburg, P. H., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.008 · Cited by 263
BDNF gene is a risk factor for schizophrenia in a Scottish population
Neves-Pereira, M., Cheung, J., Pasdar, A., Zhang, F., Breen, G. D., Yates, P., Sinclair, M., Crombie, C., Walker, N. P., & Clair, D. M. S. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001575 · Cited by 262
Mechanisms of action of atypical antipsychotic drugs
Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., & Charney, D. S. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90030-u · Cited by 253
de Foubert, G., Carney, S. L., Robinson, C. S., Destexhe, E. J., Tomlinson, R., Hicks, C. A., Murray, T. K., Gaillard, J. P., Deville, C., Xhenseval, V., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.054 · Cited by 249
Synaptopathies: diseases of the synaptome
Grant, S. G. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.02.002 · Cited by 248
Aicardi, G., Argilli, E., Cappello, S., Santi, S., Riccio, M., Thoenen, H., & Canossa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406960101 · Cited by 246
Arc regulates spine morphology and maintains network stability in vivo
Peebles, C. L., Yoo, J., Thwin, M. T., Palop, J. J., Noebels, J. L., & Finkbeiner, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006546107 · Cited by 245
Bai, O., Chlan‐Fourney, J., Bowen, R., Keegan, D. A., & Li, X. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10440 · Cited by 239
Homer Proteins Regulate Sensitivity to Cocaine
Szumlinski, K. K., Dehoff, M. H., Kang, S. H., Frys, K. A., Lominac, K. D., Klugmann, M., Rohrer, J., Griffin, W. C., Toda, S., Champtiaux, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.019 · Cited by 228
A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites
Steward, O., & Worley, P. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131146398 · Cited by 225
Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain
Raivich, G., & Behrens, A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.03.006 · Cited by 225
∆FosB: A transcriptional regulator of stress and antidepressant responses
Nestler, E. J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.034 · Cited by 220
Bottai, D., Guzowski, J. F., Schwarz, M. K., Kang, S. H., Xiao, B., Lanahan, A. A., Worley, P. F., & Seeburg, P. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00167.2002 · Cited by 217
de Bartolomeis, A., Tomasetti, C., & Iasevoli, F. (2015) · CNS Drugs · doi:10.1007/s40263-015-0278-3 · Cited by 211
Self-citationAnimal models of working memory: insights for targeting cognitive dysfunction in schizophrenia
Castner, S. A., Goldman‐Rakic, P. S., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1710-9 · Cited by 211
Making protein interactions druggable: targeting PDZ domains
Dev, K. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1578 · Cited by 198
Lipska, B. K., Khaing, Z. Z., Weickert, C. S., & Weinberger, D. R. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01633.x · Cited by 197
Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia
Szumlinski, K. K., Lominac, K. D., Kleschen, M. J., Oleson, E. B., Dehoff, M. H., Schwartz, M. K., Seeberg, P. H., Worley, P. F., & Kalivas, P. W. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00120.x · Cited by 181
Angelucci, F., Mathé, A. A., & Aloe, L. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6 · Cited by 173
Wallace, C. S., Lyford, G. L., Worley, P. F., & Steward, O. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00026.1998 · Cited by 171
Lauterborn, J. C., Rivera, S., Stinis, C., Hayes, V. Y., Isackson, P. J., & Gall, C. M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07428.1996 · Cited by 166
Memory Reconsolidation Mediates the Updating of Hippocampal Memory Content
Lee, J. L. C. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00168 · Cited by 165
Induction of c‐fos mRNA Expression in Rat Striatum by Neuroleptic Drugs
Miller, J. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01983.x · Cited by 164
Rex, C. S., Lauterborn, J. C., Lin, C., Kramár, E. A., Rogers, G. A., Gall, C. M., & LYNCH, G. S. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00336.2006 · Cited by 162
Upstream Stimulatory Factors Are Mediators of Ca2+-Responsive Transcription in Neurons
Chen, W., West, A. E., Xu, T., Corfas, G., Szentirmay, M. N., Sawadogo, M., Vinson, C., & Greenberg, M. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02572.2003 · Cited by 161
Structural Basis of Arc Binding to Synaptic Proteins: Implications for Cognitive Disease
Zhang, W., Wu, J., Ward, M. D., Yang, S., Chuang, Y.-A., Xiao, M.-F., Li, R., Leahy, D. J., & Worley, P. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.030 · Cited by 160
O'Brien, R., Xu, D., Mi, R., Tang, X., Hopf, C., & Worley, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04487.2002 · Cited by 160
Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics
GRILLO, R., Ottoni, G. L., Leke, R., Souza, D. O., Portela, L. V., & Lara, D. R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.005 · Cited by 159
MacGibbon, G. A., Lawlor, P. A., Bravo, R., & Dragunow, M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90207-0 · Cited by 152
The Neuronal Activity-Driven Transcriptome
Benito, E., & Barco, Á. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8772-z · Cited by 152
Tan, Y. L., Zhou, D. F., Cao, L. Y., Zou, Y. Z., & Zhang, X. Y. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.02.054 · Cited by 146
Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses
Lee, S.-J., Wei, M., Zhang, C., Maxeiner, S., Pak, C., Calado Botelho, S., Trotter, J., Sterky, F. H., & Südhof, T. C. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2768-16.2016 · Cited by 146
Hong, C., Yu, Y. W. ‐., Lin, C., & Tsai, S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00828-0 · Cited by 144
Panja, D., Kenney, J. W., D’Andrea, L., Zalfa, F., Vedeler, A., Wibrand, K., Fukunaga, R., Bagni, C., Proud, C. G., & Bramham, C. R. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.016 · Cited by 143
Gao, M., Sossa, K. G., Song, L., Errington, L., Cummings, L. W., Hwang, H., Kuhl, D., Worley, P. F., & Lee, H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1067-10.2010 · Cited by 143
BDNF-mediated neurotransmission relies upon a myosin VI motor complex
Yano, H., Ninan, I., Zhang, H., Milner, T. A., Arancio, O., & Chao, M. V. (2006) · Nature Neuroscience · doi:10.1038/nn1730 · Cited by 141
Role of Dopamine D2 Receptors for Antipsychotic Activity
Ginovart, N., & Kapur, S. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_2 · Cited by 141
Gärtner, A., Polnau, D. G., Staiger, V., Sciarretta, C., Minichiello, L., Thoenen, H., Bonhoeffer, T., & Körte, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3792-05.2006 · Cited by 138
Pérez-Cadahía, B., Drobic, B., & Davie, J. R. (2011) · Biochemistry and Cell Biology · doi:10.1139/o10-138 · Cited by 137
Effects of Olanzapine on Regional C-Fos Expression in Rat Forebrain
Robertson, G. S., & Fibiger, H. C. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00196-k · Cited by 135
Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum
White, N. M., & Hiroi, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6486 · Cited by 131
Time-Dependent Expression of Arc and Zif268 after Acquisition of Fear Conditioning
Lonergan, M. E., Gafford, G. M., Jarome, T. J., & Helmstetter, F. J. (2010) · Neural Plasticity · doi:10.1155/2010/139891 · Cited by 129
Chlan‐Fourney, J., Ashe, P. C., Nylen, K., Juorio, A. V., & Li, X. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03215-8 · Cited by 129
The transcription factor Fos: a Janus-type regulator in health and disease.
Durchdewald, M., Angel, P. E., & Heß, J. (2009) · PubMed · doi:10.14670/hh-24.1451 · Cited by 128
Pillai, A., Terry, A. V., & Mahadik, S. P. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.11.021 · Cited by 127
Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits
Tost, H., Braus, D. F., Hakimi, S., Ruf, M., Vollmert, C., Höhn, F., & Meyer‐Lindenberg, A. (2010) · Nature Neuroscience · doi:10.1038/nn.2572 · Cited by 127
de Bartolomeis, A., Latte, G., Tomasetti, C., & Iasevoli, F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8534-3 · Cited by 127
Self-citationGKAP orchestrates activity-dependent postsynaptic protein remodeling and homeostatic scaling
Shin, S. M., Zhang, N., Hansen, J., Gerges, N. Z., Pak, D. T. S., Sheng, M., & Lee, S. H. (2012) · Nature Neuroscience · doi:10.1038/nn.3259 · Cited by 126
Adult mice with reduced Nurr1 expression: an animal model for schizophrenia
Rojas, P., Joodmardi, E., Hong, Y., Perlmann, T., & Ögren, S. O. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001993 · Cited by 120
Managò, F., Mereu, M., Mastwal, S. S., Mastrogiacomo, R., Scheggia, D., Emanuele, M., Luca, M. A. D., Weinberger, D. R., Wang, K. H., & Papaleo, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.044 · Cited by 119
A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain
Bäckman, C. M., Perlmann, T., Wallén‐Mackenzie, Å., Hoffer, B. J., & Morales, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02149-6 · Cited by 117
Saunderson, E. A., Spiers, H., Mifsud, K. R., Gutièrrez‐Mecinas, M., Trollope, A. F., Shaikh, A., Mill, J. S., & Reul, J. M. H. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524857113 · Cited by 116
Coutellier, L. D., Beraki, S., Ardestani, P. M., Saw, N. L., & Shamloo, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046604 · Cited by 112
Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
Samaha, A., Reckless, G. E., Seeman, P. M., Diwan, M., Nóbrega, J. N., & Kapur, S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.010 · Cited by 110
Maddox, S. A., Monsey, M. S., & Schafe, G. E. (2010) · Learning & Memory · doi:10.1101/lm.1980211 · Cited by 108
Alme, M. N., Wibrand, K., Dagestad, G., & Bramham, C. R. (2007) · Neural Plasticity · doi:10.1155/2007/26496 · Cited by 103
Ċastrén, E., Berzaghi, M. D. P., Lindholm, D., & Thoenen, H. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1124 · Cited by 101
Iritani, S., Niizato, K., Nawa, H., Ikeda, K., & Emson, P. C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00112-x · Cited by 101
MicroRNA Regulation of the Synaptic Plasticity-Related Gene Arc
Wibrand, K., Pai, B., Siripornmongcolchai, T., Bittins, M., Berentsen, B., Ofte, M. L., Weigel, A., Skaftnesmo, K. O., & Bramham, C. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041688 · Cited by 101
Localization and local translation of Arc/Arg3.1 mRNA at synapses: some observations and paradoxes
Steward, O., Farris, S., Pirbhoy, P. S., Darnell, J. C., & Driesche, S. J. V. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00101 · Cited by 97
Molecular evidence of synaptic pathology in the CA1 region in schizophrenia
Matosin, N., Fernandez, F., Lum, J. S., Engel, M., Andrews, J. L., Gassen, N. C., Wagner, K. V., Schmidt, M. V., & Newell, K. A. (2016) · Schizophrenia · doi:10.1038/npjschz.2016.22 · Cited by 94
Atkins, J. B., Chlan‐Fourney, J., Nye, H. E., Hiroi, N., Carlezon, W. A., & Nestler, E. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199908)33:2 · Cited by 92
Iasevoli, F., Tomasetti, C., & de Bartolomeis, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0886-y · Cited by 91
Self-citationKimoto, S., Bazmi, H. H., & Lewis, D. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010004 · Cited by 91
de Bartolomeis, A., Manji, H. K., PhD, Iasevoli, A. F., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4173 · Cited by 88
Is schizophrenia a dopamine supersensitivity psychotic reaction?
Seeman, M. V., & Seeman, P. M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.003 · Cited by 87
Scaffold protein Homer 1: Implications for neurological diseases
Luo, P., Li, X., Fei, Z., & Poon, W. S. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.014 · Cited by 87
Deutch, A. Y., Öngür, D., & Duman, R. S. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00571-l · Cited by 87
Homer Isoforms Differentially Regulate Cocaine-Induced Neuroplasticity
Szumlinski, K. K., Abernathy, K., Oleson, E. B., Klugmann, M., Lominac, K. D., He, D., Dorit Ron, A., During, M. J., & Kalivas, P. W. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300890 · Cited by 86
Katagiri, Y., Hirata, Y., Milbrandt, J., & Guroff, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31278 · Cited by 86
Synaptic Dysfunction in Schizophrenia
Yin, D., Chen, Y., Sathyamurthy, A., Xiong, W., & Mei, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_22 · Cited by 85
Xing, G., Zhang, L., Russell, S., & Post, R. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.11.006 · Cited by 85
Bigio, B., Mathé, A. A., Sousa, V. C., Zelli, D., Svenningsson, P., McEwen, B. S., & Nasca, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603111113 · Cited by 85
Beaudry, G., Langlois, M., Weppe, I., Rouillard, C., & Lévesque, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751694.x · Cited by 83
Yano, M., & Steiner, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.019 · Cited by 83
Merchant, K. M., Dobie, D. J., Filloux, F. M., Totzke, M. T., Aravagiri, M., & Dorsa, D. M. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22817-8 · Cited by 83
Xie, H. B., Liu, Y., Zhu, Y., Ding, X., Yang, Y., & Guan, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316808111 · Cited by 82
Nur transcription factors in stress and addiction
Campos‐Melo, D., Galleguillos, D., Sánchez, N., Gysling, K., & Andrés, M. E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00044 · Cited by 81
Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations
Jarskog, L. F. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218603.25346.8f · Cited by 81
Fumagalli, F., Molteni, R., Roceri, M., Bedogni, F., Santero, R., Fossati, C., Gennarelli, M., Racagni, G., & Riva, M. A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10609 · Cited by 77
Fumagalli, F., Calabrese, F., Luoni, A., Bolis, F., Racagni, G., & Riva, M. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000150 · Cited by 77
Martínez‐Cengotitabengoa, M., MacDowell, K. S., Alberich, S., Diaz, F., García‐Bueno, B., Rodríguez–Jiménez, R., Bioque, M., Berrocoso, E., Parellada, M., Lobo, A., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv078 · Cited by 77
Amemori, K., Gibb, L., & Graybiel, A. M. (2011) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2011.00047 · Cited by 76
The Synaptic Pathology of Schizophrenia: Is Aberrant Neurodevelopment and Plasticity to Blame?
Eastwood, S. L. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59003-7 · Cited by 75
Parikh, V., Khan, M. M., & Mahadik, S. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.079 · Cited by 75
Oda, Y., Kanahara, N., & Iyo, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226228 · Cited by 74
Park, S.-W., Lee, S.-K., Kim, J.-M., Yoon, J., & Kim, Y.-H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.028 · Cited by 74
Linden, A.-M., Väisänen, J., Lakso, M., Nawa, H., Wong, G., & Ċastrén, E. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:1-2:027 · Cited by 73
Rinaldi, A., Mandillo, S., Oliverio, A., & Mele, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301176 · Cited by 72
Transcription-Factor-Dependent Control of Adult Hippocampal NeurogenesisPreprint
Beckervordersandforth, R., Zhang, C., & Lie, D. C. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018879 · Cited by 72
Plasticity‐related genes in brain development and amygdala‐dependent learning
Ehrlich, D., & Josselyn, S. A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12255 · Cited by 70
Npas4, a novel helix–loop–helix PAS domain protein, is regulated in response to cerebral ischemia
Shamloo, M., Soriano, L., von Schack, D., Rickhag, M., Chin, D. J., Gonzalez‐Zulueta, M., Gidö, G., Urfer, R., Wieloch, T. W., & Nikolich, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05172.x · Cited by 70
Gangarossa, G., Benedetto, M. D., O'Sullivan, G. J., Dunleavy, M., Alcacer, C., Bonito-Oliva, A., Henshall, D. C., Waddington, J. L., Valjent, E., & Fisone, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019415 · Cited by 69
Bloomer, W. A. C., VanDongen, H. M. A., & VanDongen, A. M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702451200 · Cited by 69
In Vivo Regulation of Homer1a Expression in the Striatum by Cocaine
Zhang, G.-C., Mao, L., Liu, X., Parelkar, N. K., Arora, A. K., Yang, L., Hains, M., Fibuch, E. E., & Wang, J. Q. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028399 · Cited by 69
Calabrese, F., Molteni, R., Gabriel, C., Mocaër, E., Racagni, G., & Riva, M. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2129-8 · Cited by 67
Polese, D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00371-8 · Cited by 66
Benedetti, F., Poletti, S., Locatelli, C., Mazza, E., Lorenzi, C., Vitali, A., Riberto, M., Brioschi, S., Vai, B., Bollettini, I., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.011 · Cited by 64
González-Pinto, A. M., Mosquera, F., Palomino, A., Alberich, S., Gutiérrez, A., Haidar, K., Vega, P., Barbeito, S., Jauregi, A. O., & Matute, C. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328338bc5a · Cited by 63
Maheux, J., Éthier, I., Rouillard, C., & Lévesque, D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080184 · Cited by 62
Langlois, M.-C., Beaudry, G., Zekki, H., Rouillard, C., & Lévesque, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00248-2 · Cited by 60
Psychotherapy and the Single Synapse
Kandel, E. R. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.2.290 · Cited by 60
Daunais, J. B., & McGinty, J. F. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00226-i · Cited by 59
Spellmann, I., Rujescu, D., Musil, R., Mayr, A. J., Giegling, I., Genius, J., Zill, P., Dehning, S., Opgen-Rhein, M., Cerovecki, A., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.06.004 · Cited by 59
Zhou, X., Moon, C., Zheng, F., Luo, Y., Soellner, D., Nuñez, J. L., & Wang, H. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22103 · Cited by 59
Ahmed, M. R., Gurevich, V. V., Dalby, K. N., Benovic, J., & Gurevich, E. V. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131987 · Cited by 57
Werme, M., Ringholm, A., Olson, L., & Brené, S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02109-0 · Cited by 57
Barnes, P., Kirtley, A., & Thomas, K. L. (2010) · Hippocampus · doi:10.1002/hipo.20879 · Cited by 56
Dietz, A., Buschermöhle, M., Aarnisalo, A. A., Vanhanen, A., Hyyrynen, T., Aaltonen, O., Löppönen, H., Zokoll, M. A., & Kollmeier, B. (2014) · Acta Oto-Laryngologica · doi:10.3109/00016489.2014.898185 · Cited by 54
Okada, R., Fujiwara, H., Mizuki, D., Araki, R., Yabe, T., & Matsumoto, K. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.064 · Cited by 54
Robinet, C., & Pellerin, L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.059 · Cited by 54
Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
Yue, Y., Kong, L., Wang, J., Li, C., Tan, L., Su, H. L., & Xu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147204 · Cited by 54
Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia
Kimoto, S., Zaki, M. M., Bazmi, H. H., & Lewis, D. A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0533 · Cited by 53
Hernandez, P. J., Schiltz, C. A., & Kelley, A. E. (2006) · Learning & Memory · doi:10.1101/lm.335006 · Cited by 53
μ‐Opioid receptor knockout mice are insensitive to methamphetamine‐induced behavioral sensitization
Shen, X., Purser, C., Tien, L., Chiu, C., Paul, I. A., Baker, R., Loh, H. H., Ho, I. K., & Ma, T. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22386 · Cited by 52
Huentelman, M. J., Muppana, L., Corneveaux, J. J., Dinu, V., Pruzin, J. J., Reiman, R., Borish, C. N., De Both, M., Ahmed, A., Todorov, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135076 · Cited by 52 · cited 1×
“Interestingly, an association of SNPs in Egr3 and Arc with schizophrenia has been proposed as a biological pathway of environmentally responsive, synaptic plasticity-related, schizophrenia risk genes (Huentelman et al., 2015).”
BackgroundPark, S. W., Lee, C. H., Lee, J. G., Lee, S. J., Kim, N. R., Choi, S. M., & Kim, Y. H. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.010 · Cited by 52
Tomasetti, C., Dell’Aversano, C., Iasevoli, F., & de Bartolomeis, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.08.022 · Cited by 51
Self-citationGenetic study of BDNF, DRD3, and their interaction in tardive dyskinesia
Zai, C. C. H., Tiwari, A. K., Luca, V. D., Müller, D. J., Bulgin, N., Hwang, R., Zai, G. C., King, N. A., Voineskos, A. N., Meltzer, H. Y., et al. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.001 · Cited by 51
The differences between typical and atypical antipsychotics: the effects on neurogenesis.
Nandra, K. S., & Agius, M. A. (2012) · PubMed · Cited by 51
Cheval, H., Chagneau, C., Levasseur, G., Veyrac, A., Biguet, N. F., Laroche, S., & Davis, S. (2011) · Hippocampus · doi:10.1002/hipo.20926 · Cited by 50
Pei, Q., Tordera, R. M., Sprakes, M., & Sharp, T. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.017 · Cited by 50
Éthier, I., Beaudry, G., St‐Hilaire, M., Milbrandt, J., Rouillard, C., & Lévesque, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300318 · Cited by 50
Iasevoli, F., Tomasetti, C., Marmo, F., Bravi, D., Arnt, J., & de Bartolomeis, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1954-0 · Cited by 49
Self-citationTomasetti, C., Dell’Aversano, C., Iasevoli, F., Marmo, F., & de Bartolomeis, A. (2011) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.025 · Cited by 49
Self-citationDoyle, S., Pyndiah, S., Gois, S. D., & Erickson, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080069 · Cited by 48
Individualizing antipsychotic drug therapy in schizophrenia: The promise of pharmacogenetics
Nnadi, C. U., & Malhotra, A. K. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0038-2 · Cited by 47
Takahashi, T., Suzuki, M., Tsunoda, M., Kawamura, Y., Takahashi, N., Tsuneki, H., Kawasaki, Y., Zhou, S.-Y., Kobayashi, S., Sasaoka, T., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.02.004 · Cited by 46
Managing Negative Symptoms of Schizophrenia: How Far Have We Come?
Kantrowitz, J. T. (2017) · CNS Drugs · doi:10.1007/s40263-017-0428-x · Cited by 46
Kontkanen, O. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00289-0 · Cited by 45
Iasevoli, F., Tomasetti, C., Ambesi‐Impiombato, A., Muscettola, G., & de Bartolomeis, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.009 · Cited by 45
Self-citationDefinition of a Bidirectional Activity-Dependent Pathway Involving BDNF and Narp
Mariga, A., Glaser, J., Mathias, L., Xu, D., Xiao, M., Worley, P., Ninan, I., & Chao, M. V. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.064 · Cited by 45
Iasevoli, F., Ambesi‐Impiombato, A., Fiore, G., Panariello, F., Muscettola, G., & de Bartolomeis, A. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358199 · Cited by 44
Self-citationChen, Q.-Y., Chen, Q., Feng, G., Wan, C., Lindpaintner, K., Wang, L., Chen, Z., Gao, Z.-S., Tang, J., Li, X.-W., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.033 · Cited by 44
Ghasemzadeh, M. B., Windham, L. K., LAKE, R. W., Acker, C. J., & Kalivas, P. W. (2008) · Synapse · doi:10.1002/syn.20577 · Cited by 44
Valenti, O., & Grace, A. A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990599 · Cited by 44
Mapping memory function in the medial temporal lobe with the immediate-early gene Arc
Sauvage, M. M., Nakamura, N. H., & Beer, Z. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.048 · Cited by 43
Cochran, S., McKerchar, C. E., MORRIS, B. J., & Pratt, J. A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00091-6 · Cited by 42
Iasevoli, F., Fiore, G., Cicale, M., Muscettola, G., & de Bartolomeis, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.02.009 · Cited by 41
Self-citationVahid-Ansari, F., Nakabeppu, Y., & Robertson, G. S. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01579.x · Cited by 41
Moser, M., Knoth, R., Bode, C., & Patterson, C. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.06.023 · Cited by 41
Modulation of behavior by scaffolding proteins of the post-synaptic density
Gao, C., Tronson, N. C., & Radulović, J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.014 · Cited by 41
Signaling pathways regulating Homer1a expression: implications for antidepressant therapy
Serchov, T., Heumann, R., van Calker, D., & Biber, K. P. H. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0267 · Cited by 41
Regulation of the Nuclear Orphan Receptor Nur77 in Bone by Parathyroid Hormone
Tetradis, S., Bezouglaia, O., Tsingotjidou, A., & Vila, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4459 · Cited by 41
de Bartolomeis, A., Tomasetti, C., Cicale, M., Yuan, P., & Manji, H. K. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.11.006 · Cited by 40
Self-citationRizig, M., McQuillin, A., Ng, A., Robinson, M., Harrison, A., Zvelebil, M., Hunt, S., & Gurling, H. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112450780 · Cited by 39
Emsley, R. A., Asmal, L., du Plessis, S., Chiliza, B., Phahladira, L. S., & Kilian, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717000642 · Cited by 39
Flagged first, then by citations
2 of the 270 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247
Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic
Yohn, S. E., Weiden, P. J., Felder, C. C., & Stahl, S. M. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.09.006 · Cited by 113
de Bartolomeis, A., Vellucci, L., Barone, A., Manchia, M., Luca, V. D., Iasevoli, F., & Correll, C. U. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108236 · Cited by 96
Self-citationde Bartolomeis, A., Barone, A., Begni, V., & Riva, M. A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106078 · Cited by 79
Polese, D., Fornaro, M., Palermo, M., Luca, V. D., & de Bartolomeis, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00210 · Cited by 78
Metadata
- Authors
- de Bartolomeis, A., Buonaguro, E. F., Latte, G., Rossi, R., Marmo, F., Iasevoli, F., & Tomasetti, C.
- Affiliations
- Federico II University Hospital (IT)
- ORCID
- Venue
- Frontiers in Behavioral Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-12-11
- Volume
- 11
- Pages
- 240-240
- ISSN
- 1662-5153 (ISSN-L)
- PMC
- PMC5732183
- OpenAlex
- W2771406275
- Cited by
- 44
- References
- 270
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 9 · 2019: 4 · 2018: 3
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Behavioral Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- immediate early genes, antipsychotic drugs, neuroplasticity, schizophrenia, epigenetics, dopamine D2 receptor, motor side effects, brain region specificity, gene expression profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review